NovaCina Revenue and Competitors
Estimated Revenue & Valuation
- NovaCina's estimated annual revenue is currently $37M per year.
- NovaCina's estimated revenue per employee is $462,300
Employee Data
- NovaCina has 80 Employees.
- NovaCina grew their employee count by 433% last year.
NovaCina's People
| Name | Title | Email/Phone |
|---|---|---|
1 | SVP R&D | Reveal Email/Phone |
2 | VP Business Development - North America | Reveal Email/Phone |
3 | VP, Business Development | Reveal Email/Phone |
4 | Supply and Logistics Officer | Reveal Email/Phone |
5 | Director Clinical Trials and Business Development | Reveal Email/Phone |
6 | Quality Assurance Manager | Reveal Email/Phone |
7 | Engineering Manager | Reveal Email/Phone |
8 | Manager Sales Enablement and Marketing | Reveal Email/Phone |
9 | Payroll Manager | Reveal Email/Phone |
10 | Chemical Compounder | Reveal Email/Phone |
NovaCina Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $17.1M | 85 | 33% | N/A | N/A |
#2 | $20.1M | 100 | -12% | N/A | N/A |
#3 | $175.3M | 872 | -7% | N/A | N/A |
#4 | $26.3M | 131 | 54% | N/A | N/A |
#5 | $6.8M | 34 | -11% | N/A | N/A |
#6 | $27.5M | 137 | -4% | N/A | N/A |
#7 | $10.7M | 53 | -42% | N/A | N/A |
#8 | $175.9M | 875 | 26% | N/A | N/A |
#9 | $13.9M | 69 | 8% | N/A | N/A |
#10 | $7.6M | 38 | 27% | N/A | N/A |
What Is NovaCina?
NovaCina is a leading supplier of sterile liquid pharmaceutical contract manufacturing services. From early-stage drug development to full-scale manufacturing, to advanced analytical studies, we have the capabilities to support you in delivering products of the highest quality to market.
keywords:N/AN/A
Total Funding
80
Number of Employees
$37M
Revenue (est)
433%
Employee Growth %
N/A
Valuation
N/A
Accelerator
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $19.8M | 81 | 5% | N/A |
#2 | $37.3M | 113 | 5% | N/A |
#3 | $38.2M | 248 | 3% | N/A |
#4 | $42.6M | 341 | 9% | N/A |
